| Market Cap | ₹29,525Cr |
| ROE | 18.88% |
| P/E Ratio(TTM) | 39.17 |
| EPS(TTM) | 48.12 |
| P/B Ratio | 7.76 |
| Dividend Yield | 0.82% |
| Industry P/E | 31.80 |
| Book Value | 242.94 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Managing Director | Nikhil Chopra |
| Founded | 1976 |
| NSE Symbol | JBCHEPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Emcure Pharmaceuticals | NA (0.00%) | 35.96 | ||
| Wockhardt | NA (0.00%) | -430.05 | ||
| Natco Pharma | NA (0.00%) | 9.79 | ||
| Cohance Lifesciences | NA (0.00%) | 46.91 |